Publications
- CCL2, CCL8, CXCL12 chemokines in resectable non-small cell lung cancer (NSCLC)2023 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Cemiplimab: monotherapy and combination therapy of NSCLC - analysis of locally advanced disease2023 | First Faculty of Medicine
- Comedication with corticosteroids and nonsteroidal antiphlogistics does not affect PD-L1 expression in non-small cell lung cancer2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové, Second Faculty of Medicine
- Lung Cancer Versus "Young Cancer": Is Non-Small Cell Lung Cancer in Young Patients a Different Entity?2022 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?2022 | Faculty of Medicine in Pilsen, Central Library of Charles University, Faculty of Medicine in Hradec Králové
- Ground-breaking ADAURA trial - osimertinib as adjuvant therapy of EGFR-mutated NSCLC2022 | First Faculty of Medicine
- Nivolumab as second-line therapy for patients with advanced NSCLC (non-small cell lung cancer)2022 | First Faculty of Medicine
- Clinical experience with durvalumab treatment2021 | First Faculty of Medicine
- Chemoimmunotherapy in the treatment of ES-SCLC2021 | First Faculty of Medicine
- NSCLC (Non-Small Cell Lung Cancer) and kidney tumor in the elderly patient with response to chemoimmunotherapy2021 | First Faculty of Medicine
Loading network view...